Driving clinical excellence through strategic partnerships - the Greater Bay Area (GBA) International Oncology Symposium 2024 co-hosted by Gleneagles Hospital Hong Kong ignites dialogue to enahnce cancer care and research.
From 23- 24 March, Gleneagles Hospital Hong Kong co-hosted the Greater Bay Area (GBA) International Oncology Symposium 2024, in partnership with The University of Hong Kong-Shenzhen Hospital and Hong Kong University’s Li Ka Shing Faculty of Medicine.
Renowned global cancer experts gathered to explore latest developments in various cancer types, precision cancer medicine, and ways to enhance the quality and effectiveness of cancer care, as well as opportunities for clinical service and research collaboration in the Greater Bay Area.
Dr Kenneth Tsang, CEO of Gleneagles Hospital Hong Kong, highlighted the hospital’s commitment to oncology care, stating, “Through our close collaboration with HKU and oncology experts, we have established several oncology centres and implemented Tumor Boards, where cases are regularly reviewed to ensure the most effective patient care plans. They also serve as platforms for exploring the latest technologies in cancer diagnosis and treatments, fostering professional and academic exchange and development.”
With insights gained from these discussions, Gleneagles Hospital Hong Kong remains at the forefront of oncology care, offering hope and improved outcomes to cancer patients across the Greater Bay Area and beyond.
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Parkway Shanghai Opens International Centre for Hepatobiliary and Pancreatic Diseases
